Biopharmaceutical Company
Appears in 1 story
Launched early 2026; IND-enabling studies planned for 2026; human trials targeted for 2028
A November 2025 study in Science showed that blocking an enzyme called 15-PGDH regrew cartilage in older mice and in human joint tissue from knee replacement patients. Blocking it shifts cartilage cells from degrading to rebuilding—without stem cells.
Updated Jun 13
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
